Actinobacillus suis is an important bacterial pathogen of healthly pigs. An O-antigen (lipopolysaccharide; LPS) serotyping system is being developed to study the prevalence and distribution of representative isolates from both healthy and diseased pigs. In a previous study, we reported that A. suis serogroup O:1 strains express LPS with a (1→6)-β-D-glucan O-antigen chain polysaccharide that is similar in structure to a key cell-wall component in yeasts, such as Saccharomyces cerevisiae and Candida albicans. This study describes the O-antigen polysaccharide chemical structure of an O:2 serogroup strain, A. suis H91-0380, which possesses a tetrasaccharide repeating block with the structure: →3)-β-D-Galp-(1→4)-[α-D-Galp-(1→6)]-β-D-Glcp-(1→6)-β-D-GlcpNAc-(1→. Studies have shown that A. suis serogroup O:2 strains are associated with severely diseased animals; therefore, work on the synthesis of a glycoconjugate vaccine employing O:2 O-antigen polysaccharide to vaccinate pigs against A. suis serogroup O:2 strains is currently underway.
Lipopolysaccharide, vaccine, Actinobacillus suis, serogroup O:2
NCBI PubMed ID: 16609699Publication DOI: 10.1139/O06-012Journal NLM ID: 8606068Publisher: Ottawa: National Research Council of Canada
Correspondence: monteiro@uoguelph.ca
Institutions: Department of Chemistry, University of Guelph, Guelph, ON N1G 2W1, Canada, National Research Council, 100 Sussex Drive, Ottawa, ON K1A 0R6, Canada, Department of Pathobiology, University of Guelph, Guelph, ON N1G 2W1, Canada
Methods: methylation, GLC-MS, NMR-2D, FAB-MS, NMR, Smith degradation, composition analysis